BrightEdge
CorporateBrightEdge is the venture and impact investment arm of the American Cancer Society.
Filter & sort
VCs, accelerators, and funds backing UK tech companies.
Investors
6,481
Combined AUM
£27.2T
under management
Investments
17,715
tracked rounds
BrightEdge is the venture and impact investment arm of the American Cancer Society.

BrightEye is a venture capital firm prominent in the educational technology space.

Brighton Park Capital is a growth equity firm focusing on entrepreneur-led, growth-stage software, healthcare and tech-enabled services companies, providing operational support alongside capital.
Bring Ventures is the venture arm of Norway Post investing in e-commerce activities.
Bristol Private Equity Club participated in Anaphite's funding round with nearly £500k.
Bristol and Bath Regional Capital is the West of England's first home-grown impact investor focused on unlocking funding for purposeful businesses, charities and social enterprises.